MGAM and Parkinson disease: Furthermore, exogenous delivery of miR-124 suppressed p62 and p-p38 expression and attenuated the activation of MG in MPTP-treated mice, indicating that miR-124 inhibits neuroinflammation during PD development by targeting p62, p38, and autophagy (Yao et al., 2019).